SPC awards Zydus Cadila Best Supplier 2012
State Pharmaceutical Corporation of Sri Lanka (SPC), the largest healthcare customer in the country, has awarded the Best Supplier for the year 2012 to Zydus Cadila, the fourth largest pharmaceutical company in India.
Zydus Cadila, a 60-year-old company, whose distributor in Sri Lanka is Swiss Biogenics Limited (SBL), has been operating in the country since 1985 and has created a strong foothold for them in the local market. Zydus Cadila is also one of the first Indian pharmaceutical companies to commence operations in Sri Lanka in a significant manner.
As Ashok Bhatia, President (International Business) of the company says, one in every six medical prescription in Sri Lanka would have a Zydus product and is proof of the company’s strong presence in Sri Lanka’s vibrant pharmaceutical industry.
“Our company was started by our late Founder Chairman Ramanbhai B. Patel, who was a first generation entrepreneur in newly independent India. When Zydus Cadila came into being, 90 percent of the industry was dominated by multinational companies. Therefore, the only way forward for us, since inception, was to offer high quality products at a good price. ‘Cadila for Quality’ was not just our credo but our business philosophy as well. That is the secret of our success, not only in India but also across the world,” Bhatia explains.
“Capturing the global market was a highly challenging task. For that, we realized that we needed to develop our own products. We were one of the first Indian companies to achieve remarkable success in the research sector. We are the first Indian company to receive an approval for its own patented research product.
The discovery research product is ‘Lipaglyn’, which belongs to a novel class of drugs called the Glitazars. It is the only drug in the world to treat diabetic dyslipidemia or Hypertriglyceridemia in Type II diabetes. It gives patients suffering from diabetic dyslipidemia the option of a oncedaily oral therapy and has beneficial effect on both lipid parameters as well as glycemic control while addressing all safety concerns. This is an achievement which we are extremely proud of,” he said.
In Sri Lanka, he says, the company has found the ideal partner in SBL, who has the right infrastructure and believes in the same values and principles as Zydus Cadila.